These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

647 related articles for article (PubMed ID: 34983709)

  • 21. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
    Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety Monitoring of an Additional Dose of COVID-19 Vaccine - United States, August 12-September 19, 2021.
    Hause AM; Baggs J; Gee J; Marquez P; Myers TR; Shimabukuro TT; Shay DK
    MMWR Morb Mortal Wkly Rep; 2021 Oct; 70(39):1379-1384. PubMed ID: 34591835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Curbing COVID-19 Vaccine Hesitancy from a Dermatological Standpoint: Analysis of Cutaneous Reactions in the Vaccine Adverse Event Reporting System (VAERS) Database.
    Falotico JM; Desai AD; Shah A; Ricardo JW; Lipner SR
    Am J Clin Dermatol; 2022 Sep; 23(5):729-737. PubMed ID: 35931925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases.
    McMahon DE; Amerson E; Rosenbach M; Lipoff JB; Moustafa D; Tyagi A; Desai SR; French LE; Lim HW; Thiers BH; Hruza GJ; Blumenthal KG; Fox LP; Freeman EE
    J Am Acad Dermatol; 2021 Jul; 85(1):46-55. PubMed ID: 33838206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hesitancy and reactogenicity to mRNA-based COVID-19 vaccines-Early experience with vaccine rollout in a multi-site healthcare system.
    Al-Obaydi S; Hennrikus E; Mohammad N; Lehman EB; Thakur A; Al-Shaikhly T
    PLoS One; 2022; 17(8):e0272691. PubMed ID: 35930586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urticaria exacerbations and adverse reactions in patients with chronic urticaria receiving COVID-19 vaccination: Results of the UCARE COVAC-CU study.
    Kocatürk E; Salameh P; Sarac E; Vera Ayala CE; Thomsen SF; Zuberbier T; Ensina LF; Popov TA; van Doorn MBA; Giménez-Arnau AM; Asero R; Criado PR; Aarestrup FM; AbdulHameed Ansari Z; Al Abri S; Al-Ahmad M; Al Hinai B; Allenova A; Al-Nesf M; Altrichter S; Arnaout R; Bartosińska J; Bauer A; Bernstein JA; Bizjak M; Bonnekoh H; Bouillet L; Brzoza Z; Calvalcanti Dela Bianca Melo AC; Campinhos FL; Carne E; Purayil SC; Cherrez-Ojeda I; Chong-Neto HJ; Christoff G; Conlon N; Jardim Criado RF; Cvenkel K; Damadoglu E; Danilycheva I; Day C; de Montjoye L; Demir S; Ferucci SM; Fomina D; Fukunaga A; Garcia E; Gelincik A; Göbel JH; Godse K; Gonçalo M; Gotua M; Grattan C; Gugala A; Guillet C; Kalyoncu AF; Karakaya G; Kasperska-Zając A; Katelaris CH; Khoshkhui M; Kleinheinz A; Kolacinska-Flont M; Kolkhir P; Košnik M; Krasowska D; Kumaran MS; Kuprys-Lipinska I; Kurowski M; Kuznetsova EV; Larenas-Linnemann D; Lebedkina MS; Lee Y; Makris M; Gómez RM; Nasr I; Neisinger S; Oda Y; Kara RÖ; Palitot EB; Papapostolou N; Salvador Parisi CA; Pesque D; Peter J; Petkova E; Ridge K; Rudenko M; Rutkowski K; Saini SS; Salman A; Sanchez J; Şekerel B; Serdotetskova SA; Serpa FS; Dikicier BS; Sidiropoulos N; Sikora A; Sørensen JA; Soria A; Kucuk OS; Thalappil SR; Tomaszewska K; Tuncay G; Unal D; Valle S; van Lindonk E; Vestergaard C; Meshkova RY; Vitchuk A; Xepapadaki P; Ye YM; Zalewska-Janowska A; Zamlynski M; Maurer M
    J Allergy Clin Immunol; 2023 Nov; 152(5):1095-1106. PubMed ID: 37574079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety Monitoring after the BNT162b2 COVID-19 Vaccine among Adults Aged 75 Years or Older.
    Choi YY; Kim MK; Kwon HC; Kim GH
    J Korean Med Sci; 2021 Nov; 36(45):e318. PubMed ID: 34811980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myocarditis following COVID-19 vaccination in adolescents and adults: a cumulative experience of 2021.
    Ilonze OJ; Guglin ME
    Heart Fail Rev; 2022 Nov; 27(6):2033-2043. PubMed ID: 35449353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach.
    Greenhawt M; Dribin TE; Abrams EM; Shaker M; Chu DK; Golden DBK; Akin C; Anagnostou A; ALMuhizi F; Alqurashi W; Arkwright P; Baldwin JL; Banerji A; Bégin P; Ben-Shoshan M; Bernstein J; Bingemann TA; Bindslev-Jensen C; Blumenthal K; Byrne A; Cahill J; Cameron S; Campbell D; Campbell R; Cavender M; Chan ES; Chinthrajah S; Comberiati P; Eastman JJ; Ellis AK; Fleischer DM; Fox A; Frischmeyer-Guerrerio PA; Gagnon R; Garvey LH; Grayson MH; Isabwe GAC; Hartog N; Hendron D; Horner CC; Hourihane JO; Iglesia E; Kan M; Kaplan B; Katelaris CH; Kim H; Kelso JM; Khan DA; Lang D; Ledford D; Levin M; Lieberman JA; Loh R; Mack DP; Mazer B; Mody K; Mosnaim G; Munblit D; Mustafa SS; Nanda A; Nathan R; Oppenheimer J; Otani IM; Park M; Pawankar R; Perrett KP; Peter J; Phillips EJ; Picard M; Pitlick M; Ramsey A; Rasmussen TH; Rathkopf MM; Reddy H; Robertson K; Rodriguez Del Rio P; Sample S; Sheshadri A; Sheik J; Sindher SB; Spergel JM; Stone CA; Stukus D; Tang MLK; Tracy JM; Turner PJ; Vander Leek TK; Wallace DV; Wang J; Wasserman S; Weldon D; Wolfson AR; Worm M; Yacoub MR
    J Allergy Clin Immunol; 2023 Aug; 152(2):309-325. PubMed ID: 37295474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Self-reported High-Risk Allergy History With Allergy Symptoms After COVID-19 Vaccination.
    Li L; Robinson LB; Patel R; Landman AB; Fu X; Shenoy ES; Hashimoto DM; Banerji A; Wickner PG; Samarakoon U; Mancini CM; Zhang Y; Blumenthal KG
    JAMA Netw Open; 2021 Oct; 4(10):e2131034. PubMed ID: 34698847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Reasons for allergology consultations prior to COVID-19 vaccination and their outcomes : Two-year experience of an allergy center in North Rhine-Westphalia].
    Leonidou Floruß E; Demidova A; Hofmann SC; Balakirski G
    Dermatologie (Heidelb); 2023 Jul; 74(7):511-519. PubMed ID: 37140637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequency and Characteristics of Nodal and Deltoid FDG and
    Schroeder DG; Jang S; Johnson DR; Takahashi H; Navin PJ; Broski SM; Thorpe MP; Johnson GB; Young JR
    AJR Am J Roentgenol; 2021 Nov; 217(5):1206-1216. PubMed ID: 34009000
    [No Abstract]   [Full Text] [Related]  

  • 33. mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach.
    Banerji A; Wickner PG; Saff R; Stone CA; Robinson LB; Long AA; Wolfson AR; Williams P; Khan DA; Phillips E; Blumenthal KG
    J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1423-1437. PubMed ID: 33388478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic Spontaneous Urticaria Following mRNA COVID-19 Booster Vaccination at a Military Academy.
    Miller MA; Raffetto ER; Lee RU
    Mil Med; 2024 Feb; 189(3-4):e911-e914. PubMed ID: 37725042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early experience of COVID-19 vaccine-related adverse events among adolescents and young adults with rheumatic diseases: A single-center study.
    Haslak F; Gunalp A; Cebi MN; Yildiz M; Adrovic A; Sahin S; Barut K; Kasapcopur O
    Int J Rheum Dis; 2022 Mar; 25(3):353-363. PubMed ID: 34978376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Vaccination approach in patients with an allergic reaction to COVID-19 vaccines or at risk of developing allergic reactions].
    Özden Ş; Tepetam FM; Atik Ö
    Tuberk Toraks; 2023 Jun; 71(2):166-175. PubMed ID: 37345399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.
    Gargano JW; Wallace M; Hadler SC; Langley G; Su JR; Oster ME; Broder KR; Gee J; Weintraub E; Shimabukuro T; Scobie HM; Moulia D; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Jul; 70(27):977-982. PubMed ID: 34237049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020.
    ;
    MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(2):46-51. PubMed ID: 33444297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biphasic anaphylaxis after exposure to the first dose of Pfizer-BioNTech COVID-19 mRNA vaccine.
    Abi Zeid Daou C; Natout MA; El Hadi N
    J Med Virol; 2021 Oct; 93(10):6027-6029. PubMed ID: 34050949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful Desensitization to mRNA COVID-19 Vaccine in a Case Series of Patients With a History of Anaphylaxis to the First Vaccine Dose.
    AlMuhizi F; Ton-Leclerc S; Fein M; Tsoukas C; Garvey LH; Lee D; Ben-Shoshan M; Isabwe GAC; Copaescu AM
    Front Allergy; 2022; 3():825164. PubMed ID: 35386647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.